GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » HST Global Inc (OTCPK:HSTC) » Definitions » Net-Net Working Capital

HST Global (HST Global) Net-Net Working Capital : $-0.11 (As of Dec. 2023)


View and export this data going back to 2002. Start your Free Trial

What is HST Global Net-Net Working Capital?

In calculating the Net-Net Working Capital (NNWC), Benjamin Graham assumed that a company's accounts receivable is only worth 75% its value, its inventory is only worth 50% of its value, but its liabilities have to be paid in full. In addition, Graham believed that preferred stock belongs on the liability side of the balance sheet, not as part of capital and surplus. This is a conservative way of estimating the company's value.

HST Global's Net-Net Working Capital for the quarter that ended in Dec. 2023 was $-0.11.

The industry rank for HST Global's Net-Net Working Capital or its related term are showing as below:

HSTC's Price-to-Net-Net-Working-Capital is not ranked *
in the Biotechnology industry.
Industry Median: 4
* Ranked among companies with meaningful Price-to-Net-Net-Working-Capital only.

HST Global Net-Net Working Capital Historical Data

The historical data trend for HST Global's Net-Net Working Capital can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

HST Global Net-Net Working Capital Chart

HST Global Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Net-Net Working Capital
Get a 7-Day Free Trial Premium Member Only Premium Member Only - -0.03 -0.06 -0.08 -0.11

HST Global Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Net-Net Working Capital Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.08 -0.09 -0.10 -0.11 -0.11

Competitive Comparison of HST Global's Net-Net Working Capital

For the Biotechnology subindustry, HST Global's Price-to-Net-Net-Working-Capital, along with its competitors' market caps and Price-to-Net-Net-Working-Capital data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


HST Global's Price-to-Net-Net-Working-Capital Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, HST Global's Price-to-Net-Net-Working-Capital distribution charts can be found below:

* The bar in red indicates where HST Global's Price-to-Net-Net-Working-Capital falls into.



HST Global Net-Net Working Capital Calculation

HST Global's Net-Net Working Capital (NNWC) per share for the fiscal year that ended in Dec. 2023 is calculated as

Net-Net Working Capital(A: Dec. 2023 )
=(Cash, Cash Equivalents, Marketable Securities+0.75 * Accounts Receivable+0.5 * Total Inventories-Total Liabilities
-Preferred Stock-Minority Interest)/Shares Outstanding (EOP)
=(0.002+0.75 * 0+0.5 * 0-0.594
-0-0)/5.24858
=-0.11

HST Global's Net-Net Working Capital (NNWC) per share for the quarter that ended in Dec. 2023 is calculated as

Net-Net Working Capital(Q: Dec. 2023 )
=(Cash, Cash Equivalents, Marketable Securities+0.75 * Accounts Receivable+0.5 * Total Inventories-Total Liabilities
-Preferred Stock-Minority Interest)/Shares Outstanding (EOP)
=(0.002+0.75 * 0+0.5 * 0-0.594
-0-0)/5.24858
=-0.11

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In calculating the Net-Net Working Capital (NNWC), Benjamin Graham assumed that a company's accounts receivable is only worth 75% its value, its inventory is only worth 50% of its value, but its liabilities have to be paid in full.

In addition, Graham believed that preferred stock belongs on the liability side of the balance sheet, not as part of capital and surplus. In "Security Analysis", preferred stock is dubbed "an imperfect creditorship position" that is best placed on the balance sheet alongside funded debt.

This is a conservative way of estimating the company's value.


HST Global  (OTCPK:HSTC) Net-Net Working Capital Explanation

One research study, covering the years 1970 through 1983 showed that portfolios picked at the beginning of each year, and held for one year, returned 29.4 percent, on average, over the 13-year period, compared to 11.5 percent for the S&P 500 Index. Other studies of Graham's strategy produced similar results.

Benjamin Graham looked for companies whose market values were less than two-thirds of their net-net value. They are collected under our Net-Net screener.


HST Global Net-Net Working Capital Related Terms

Thank you for viewing the detailed overview of HST Global's Net-Net Working Capital provided by GuruFocus.com. Please click on the following links to see related term pages.


HST Global (HST Global) Business Description

Traded in Other Exchanges
N/A
Address
150 Research Drive, Hampton, VA, USA, 23666
HST Global Inc is an integrated health and wellness biotechnology company. It is engaged in developing and acquiring a network of Wellness Centers that are focused on the homeopathic and alternative treatment of late-stage cancer. Further, it primarily focuses on homeopathic and alternative product candidates that are undergoing or have already completed clinical testing. The activities are generally carried out through the region of the United States.
Executives
Wesley D. Tate officer: CFO and Secretary C/O HEALTH SOURCE TECHNOLOGIES, INC., 150 RESEARCH DRIVE, HAMPTON VA 23666
Ronald R. Howell director, officer: CEO and Chairman C/O HEALTH SOURCE TECHNOLOGIES, INC., 150 RESEARCH DRIVE, HAMPTON VA 23666
Pnc Labs Inc 10 percent owner 429 W PLUMB LANE, RENO NV 89509
Chun Ka Tsun director, 10 percent owner, officer: CEO TG WANASPORTS MANAGEMENT HOLDINGS, 8/F NO 211 JOHNSTON ROAD, WAN CHAI K3 00000
Chen Tsz King 10 percent owner FUGU ENTERPRISE INC, UNIT A 8TH FLOOR NO 65 SING WOOD ROAD, HAPPY VALLEY K3 00000
Li Sze Tang 10 percent owner FLAT G, 8/FL TOWER THREE, THE WATERFRONT, 1 AUSTIN ROAD WEST, TST K3 00000
Andre E Todd director 746 HILLGIRT CIRCLE, OAKLAND CA 94610
Aaron Etra director 1350 AVE OF AMERICAS, 29TH FLOOR, NEW YORK NY 10019
Communications Holding Corp 10 percent owner
Alan Lew director, 10 percent owner, officer: President 2 DOGWOOD DR, SCARSDALE NY 10583

HST Global (HST Global) Headlines